Verastem (VSTM) Total Debt Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 2.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30% |
| Dec 31, 2025 | 87.43% |
| Sep 30, 2025 | 92.82% |
| Jun 30, 2025 | 84.23% |
| Mar 31, 2025 | 78.14% |
| Dec 31, 2024 | 1.59% |
| Sep 30, 2024 | 1.52% |
| Jun 30, 2024 | 1.45% |
| Mar 31, 2024 | 1.39% |
| Dec 31, 2023 | 63.44% |
| Sep 30, 2023 | 63.58% |
| Jun 30, 2023 | 63.70% |
| Mar 31, 2023 | 63.82% |
| Sep 30, 2020 | 2.34% |
| Jun 30, 2020 | 2.34% |
| Mar 31, 2020 | 42.16% |
| Dec 31, 2019 | 40.82% |
| Sep 30, 2019 | 39.18% |
| Jun 30, 2019 | 39.23% |
| Mar 31, 2019 | 66.39% |
| Dec 31, 2018 | 70.10% |
| Sep 30, 2018 | 973.36% |
| Jun 30, 2018 | 986.09% |
| Mar 31, 2018 | 563.09% |